Lataa...
Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
Current therapies for advanced hepatocellular carcinoma (HCC) are marginally effective and exacerbate underlying liver disease. The ability of immunotherapy to elicit nontoxic, systemic, long-lived anti-tumor activity makes it particularly well-suited for use in the setting of HCC. While therapeutic...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3376967/ https://ncbi.nlm.nih.gov/pubmed/22720211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.1.1.18344 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|